the efficacy of psk was recognized in the patients with normal levels of all glycoproteins in gastric cancer , and with normal levels of cea or scc or tpa and abnormal levels of one or more aprs in both gastric and esophageal cancer , and with positive hla-b40 antigen .
C0024623
gastric cancer
C0038351
gastric